Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy
NCT02001519
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
AC4-CDDP4
Sponsor
Asan Medical Center